© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).This study aims to determine prevalence and frequency of use of novel psychoactive substances (NPS) and to identify the factors associated with NPS use in an Italian sample of patients diagnosed with substance use disorder (SUD). Prevalence and correlates of NPS knowledge and use were assessed in 185 patients with SUD in three addiction services (Padova, Belluno, Feltre) in the Veneto region with an ad-hoc designed survey. Two thirds of the samples reported knowing NPS and one third reported using them. NP...
Background Novel psychoactive substances (NPS) are new narcotic or psychotropic drugs that are not ...
Novel Psychoactive Substances (NPS) are chemical substances that have been synthesised to cause simi...
Continued diversification and use of new psychoactive substances (NPS) across Europe remains a publi...
This study aims to determine prevalence and frequency of use of novel psychoactive substances (NPS) ...
Objective: Comorbidities between psychiatric diseases and consumption of traditional substances of a...
© 2017 John Wiley & Sons, Ltd. This is the peer reviewed version of the following article: Acciavatt...
INTRODUCTION: As Novel psychoactive substances (NPS) are conceived to mimic the effects of common il...
Introduction: Over the past 10 years, a large number of New Psychoactive Substances (NPS) have enter...
This is an open access article distributed under the Creative Commons Attribution License which perm...
INTRODUCTION: Novel psychoactive substances (NPS; a.k.a. 'legal highs' or 'smart drugs') are adverti...
Copyright © 2014 Giovanni Martinotti et al. This is an open access article distributed under the Cre...
Purpose: There is evidence that novel psychoactive substances (NPS) are commonly used by people wi...
Funding Information: This study was partly funded by the European Project entitled Analysis, Knowled...
Objective: Comorbidities between psychiatric diseases and use of traditional substances of abuse are...
BackgroundNovel psychoactive substances (NPS) are new narcotic or psychotropic drugs that are not co...
Background Novel psychoactive substances (NPS) are new narcotic or psychotropic drugs that are not ...
Novel Psychoactive Substances (NPS) are chemical substances that have been synthesised to cause simi...
Continued diversification and use of new psychoactive substances (NPS) across Europe remains a publi...
This study aims to determine prevalence and frequency of use of novel psychoactive substances (NPS) ...
Objective: Comorbidities between psychiatric diseases and consumption of traditional substances of a...
© 2017 John Wiley & Sons, Ltd. This is the peer reviewed version of the following article: Acciavatt...
INTRODUCTION: As Novel psychoactive substances (NPS) are conceived to mimic the effects of common il...
Introduction: Over the past 10 years, a large number of New Psychoactive Substances (NPS) have enter...
This is an open access article distributed under the Creative Commons Attribution License which perm...
INTRODUCTION: Novel psychoactive substances (NPS; a.k.a. 'legal highs' or 'smart drugs') are adverti...
Copyright © 2014 Giovanni Martinotti et al. This is an open access article distributed under the Cre...
Purpose: There is evidence that novel psychoactive substances (NPS) are commonly used by people wi...
Funding Information: This study was partly funded by the European Project entitled Analysis, Knowled...
Objective: Comorbidities between psychiatric diseases and use of traditional substances of abuse are...
BackgroundNovel psychoactive substances (NPS) are new narcotic or psychotropic drugs that are not co...
Background Novel psychoactive substances (NPS) are new narcotic or psychotropic drugs that are not ...
Novel Psychoactive Substances (NPS) are chemical substances that have been synthesised to cause simi...
Continued diversification and use of new psychoactive substances (NPS) across Europe remains a publi...